695 related articles for article (PubMed ID: 31708402)
1. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
[TBL] [Abstract][Full Text] [Related]
2. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
[TBL] [Abstract][Full Text] [Related]
3. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
4. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
5. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.
Li Y; Zhang Q; Yin X; Yang W; Du Y; Hou P; Ge J; Liu C; Zhang W; Zhang X; Wu Y; Li H; Liu K; Wu C; Song Z; Zhao Y; Shi Y; Deng H
Cell Res; 2011 Jan; 21(1):196-204. PubMed ID: 20956998
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cell generation from bovine somatic cells indicates unmet needs for pluripotency sustenance.
Pillai VV; Kei TG; Reddy SE; Das M; Abratte C; Cheong SH; Selvaraj V
Anim Sci J; 2019 Sep; 90(9):1149-1160. PubMed ID: 31322312
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
[TBL] [Abstract][Full Text] [Related]
8. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
9. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells.
Heng JC; Feng B; Han J; Jiang J; Kraus P; Ng JH; Orlov YL; Huss M; Yang L; Lufkin T; Lim B; Ng HH
Cell Stem Cell; 2010 Feb; 6(2):167-74. PubMed ID: 20096661
[TBL] [Abstract][Full Text] [Related]
10. Human fibroblast reprogramming to pluripotent stem cells regulated by the miR19a/b-PTEN axis.
He X; Cao Y; Wang L; Han Y; Zhong X; Zhou G; Cai Y; Zhang H; Gao P
PLoS One; 2014; 9(4):e95213. PubMed ID: 24740298
[TBL] [Abstract][Full Text] [Related]
11. Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.
An Z; Liu P; Zheng J; Si C; Li T; Chen Y; Ma T; Zhang MQ; Zhou Q; Ding S
Cell Rep; 2019 Nov; 29(7):1986-2000.e8. PubMed ID: 31722212
[TBL] [Abstract][Full Text] [Related]
12. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
[TBL] [Abstract][Full Text] [Related]
13. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts.
Narayan S; Bryant G; Shah S; Berrozpe G; Ptashne M
Cell Rep; 2017 Aug; 20(7):1585-1596. PubMed ID: 28813671
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-302 increases reprogramming efficiency via repression of NR2F2.
Hu S; Wilson KD; Ghosh Z; Han L; Wang Y; Lan F; Ransohoff KJ; Burridge P; Wu JC
Stem Cells; 2013 Feb; 31(2):259-68. PubMed ID: 23136034
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
17. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
18. Induced pluripotent stem cells from goat fibroblasts.
Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
[TBL] [Abstract][Full Text] [Related]
19. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
[TBL] [Abstract][Full Text] [Related]
20. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
